Kindstar Globalgene Technology, Inc. (HKG:9960)
Hong Kong
· Delayed Price · Currency is HKD 1.350
-0.030 (-2.17%)
May 22, 2025, 4:08 PM HKT
HKG:9960 Revenue
In the year 2024, Kindstar Globalgene Technology had annual revenue of 927.57M CNY, down -4.10%. Kindstar Globalgene Technology had revenue of 454.23M in the half year ending December 31, 2024, a decrease of -37.53%.
Revenue
927.57M CNY
Revenue Growth
-4.10%
P/S Ratio
1.41
Revenue / Employee
308.06K CNY
Employees
3,011
Market Cap
1.40B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 32.53B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Innovent Biologics | 10.03B |
| Alibaba Health Information Technology | 32.81B |
| Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |
| Sino Biopharmaceutical | 30.72B |